SCHEMBL26019602

SCHEMBL26019602

CNC(=O)C(CC(N)=O)NC(C)=O

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GNPAT O15228 1/20 0.41
ECE1 P42892 4/20 0.40
BMP1 P13497 3/20 0.40
KDM4E B2RXH2 1/20 0.39
MAPT P10636 1/20 0.39
THRB P10828 1/20 0.39
ALOX15 P16050 1/20 0.39
NFKB1 P19838 1/20 0.39
PTGS2 P35354 1/20 0.39
THPO P40225 1/20 0.39
RECQL P46063 1/20 0.39
BLM P54132 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
ALDH1A1 P00352 1/20 0.38
MMP2 P08253 1/20 0.36
MMP9 P14780 1/20 0.36
MMP8 P22894 1/20 0.36
PDCD1LG2 Q9BQ51 1/20 0.35
CD274 Q9NZQ7 1/20 0.35
CHRM2 P08172 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13451427 1.00 GNPAT (0.41) GNPATECE1BMP1KDM4EMAPT
SCHEMBL16152186 0.87 BMP1 (0.54) GNPATECE1BMP1MMP8CHRM2
SCHEMBL13474992 0.83 KDM4E (0.42) GNPATBMP1KDM4EMAPTTHRB
SCHEMBL13645142 0.83 BMP1 (0.61) GNPATECE1BMP1MMP8MMP1
SCHEMBL26019623 0.82 BMP1 (0.41) ECE1BMP1MMP2MMP9MMP8
SCHEMBL21422285 0.82 ECE1 (0.53) GNPATECE1KDM4EMAPTTHRB
SCHEMBL19277912 0.82 MAPT (0.38) GNPATBMP1KDM4EMAPTTHRB
SCHEMBL21398592 0.82 BMP1 (0.41) GNPATBMP1KDM4EMAPTTHRB
SCHEMBL26444807 0.82 GNPAT (0.53) GNPATBMP1KDM4EMAPTTHRB
SCHEMBL13637922 0.81 KDM4E (0.43) GNPATECE1KDM4EMAPTTHRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023118359-A1 RHABDOBRANINS AND THEIR MEDICAL USE MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) 2023-06-29 WO disclosed